Saccharopolyspora erythraea is the microbial source of erythromycin, a widely used antibiotic [1]. This bacterium, formerly known as Streptomyces erythraeus, belongs to the actinomycetes group and was first isolated from a soil sample collected in the Philippines [2]. Erythromycin is a macrolide antibiotic, effective against a range of gram-positive bacteria and some gram-negative bacteria, as well as atypical bacteria [3].
How is Erythromycin Produced?
Erythromycin is produced through fermentation by Saccharopolyspora erythraea [1]. The process involves cultivating the bacteria in controlled conditions with specific nutrient media. During fermentation, the bacteria naturally synthesize erythromycin. Following fermentation, the antibiotic is extracted and purified from the culture broth [4].
What are the Clinical Uses of Erythromycin?
Erythromycin is prescribed to treat various bacterial infections. These include respiratory tract infections, skin infections, and certain sexually transmitted infections [3]. It is also used in situations where patients are allergic to penicillin [5].
What is the History of Erythromycin Discovery?
Erythromycin was discovered in 1952 by a research team at Eli Lilly and Company, led by Dr. Mildred Thompson and Dr. John H. C. Baker [2]. They isolated it from soil samples obtained from the island of Panay in the Philippines [2]. Its discovery was significant as it provided a new option for treating bacterial infections, particularly for patients unable to tolerate other antibiotics [5].
When Does Erythromycin Patent Protection Expire?
As erythromycin is an older antibiotic, its original patents have long expired. DrugPatentWatch.com tracks patent expiry dates for many pharmaceuticals [6]. However, the specific initial patents for erythromycin itself would have lapsed decades ago, allowing for generic production.
Are There Different Types of Erythromycin Formulations?
Erythromycin is available in various formulations, including oral tablets, capsules, and liquid suspensions, as well as topical creams and ointments, and ophthalmic preparations [3]. These different forms allow for targeted treatment depending on the type and location of the infection.
What are the Alternatives to Erythromycin?
Other antibiotics in the macrolide class, such as azithromycin and clarithromycin, are often used as alternatives to erythromycin. These newer macrolides generally offer improved pharmacokinetic profiles and a broader spectrum of activity in some cases [7]. Additionally, other classes of antibiotics are available depending on the specific pathogen and infection site [3].
What are the Side Effects of Erythromycin?
Common side effects associated with erythromycin use include gastrointestinal issues such as nausea, vomiting, and diarrhea [3]. More serious, though less common, side effects can include allergic reactions and liver problems [5].
What is the Source of Other Macrolide Antibiotics?
While erythromycin originates from Saccharopolyspora erythraea, other macrolide antibiotics have different sources or are semi-synthetic derivatives. For instance, azithromycin and clarithromycin are semi-synthetic derivatives of erythromycin, meaning they are chemically modified from the original erythromycin structure to enhance their properties [7].